Omalizumab treatment associated with Churg-Strauss vasculitis

被引：19

作者：

Bargagli, Elena ^{[1
]}

Rottoli, Paola ^{[1
]}

机构：

[1] Univ Siena, Dept Clin Med & Immunol, Resp Dis Sect, IT-53100 Siena, Italy

来源：

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY | 2008年 / 145卷 / 03期

关键词：

D O I：

10.1159/000109296

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：268 / 268

页数：1

共 5 条

[1] GINA guidelines on asthma and beyond [J].

Bousquet, J. ;

Clark, T. J. H. ;

Hurd, S. ;

Khaltaev, N. ;

Lenfant, C. ;

O'Byrne, P. ;

Sheffer, A. .

ALLERGY, 2007, 62 (02) :102-112

[2] Administration of anti-IgE to a Churg-Strauss syndrome patient [J].

Giavina-Bianchi, Pedro ;

Giavina-Bianchi, Mara ;

Agondi, Rosana ;

Kalil, Jorge .

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2007, 144 (02) :155-158

[3] Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy [J].

Holgate, ST ;

Djukanovic, R ;

Casale, T ;

Bousquet, J .

CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (04) :408-416

[4] Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment):: INNOVATE [J].

Humbert, M ;

Beasley, R ;

Ayres, J ;

Slavin, R ;

Hébert, J ;

Bousquet, J ;

Beeh, KM ;

Ramos, S ;

Canonica, GW ;

Hedgecock, S ;

Fox, H ;

Blogg, M ;

Surrey, K .

ALLERGY, 2005, 60 (03) :309-316

[5]

Winchester DE, 2006, NEW ENGL J MED, V355, P1281

← 1 →